Healthcare Services

Disease Registry Software Market Expanding with Personalized Medicine Adoption

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Disease Registry Software Market From 2026 To 2030?

The disease registry software market has shown rapid expansion in recent years. This market is projected to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be attributed to several factors including the rising digitization of patient records, the proliferation of disease-specific research programs, stricter regulatory reporting requirements, the wider adoption of electronic health records, and the increasing application of data-driven clinical decision tools.

The disease registry software market is anticipated to experience substantial expansion over the upcoming years, reaching a size of $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This expansion during the forecast period is fueled by several factors, including a heightened demand for population health analytics, greater integration with AI-driven clinical insights, the broader deployment of cloud-based registries, an increased emphasis on outcomes-based healthcare, and a growing utilization of real-world data in clinical research. Key trends expected during the same period encompass the growing uptake of integrated disease registry platforms, increased reliance on cloud-based patient data management, an intensified focus on regulatory-compliant data reporting, the broadening of EHR-integrated registry solutions, and a stronger emphasis on gathering real-world evidence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Key Drivers Are Affecting The Disease Registry Software Market Development?

The increasing embrace of personalized medicine is projected to drive the growth of the disease registry software market moving forward. Personalized medicine refers to a medical strategy that customizes treatment and prevention plans for an individual based on their unique genetic composition, lifestyle, and environment. The rising adoption of personalized medicine is primarily attributed to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments for individuals. Disease registry software aids personalized medicine by systematically collecting and managing patient health data, thereby facilitating customized treatment plans and enhancing clinical decision-making. This software also streamlines data access and analysis, improving patient outcomes and furthering precision healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Therefore, the expanding adoption of personalized medicine is propelling the growth of the disease registry software market.

How Are Segments Identified Within The Disease Registry Software Market Segment Framework?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

What Trends Are Transforming The Disease Registry Software Market?

Companies operating within the disease registry software market are increasingly concentrating on the development of patient-centric registries, including digital registers, designed to track outcomes and facilitate personalized care. These digital registers are electronic systems or software platforms that systematically gather, store, and manage patient health information, effectively replacing traditional paper-based registries. For example, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, launched its CONNECT-HCM Registry. This nationwide digital registry is intended to improve the understanding and management of hypertrophic cardiomyopathy (HCM), which stands as the most common genetic cardiovascular disease. The registry allows for direct patient enrollment beyond individual centers, thereby addressing long-standing gaps in diagnosis and care. Furthermore, this platform integrates registry data with electronic health records via Arboretum’s Hugo Connect platform, aiding researchers in monitoring symptoms, imaging, treatments, and outcomes over time.

Who Are The Companies Competing Within The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Get The Full Disease Registry Software Market Report:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Region Is The Largest In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Disease Registry Software Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Healthcare Compliance Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795